Homburger advised Idorsia on the public repurchase offer to exchange a series of unsecured convertible bonds with a principal amount of CHF 800 m in aggregate against newly issued “Pay-If-You-Can” notes. The context The senior unsecured
Bär & Karrer is advising Deutsche Private Equity (DPE) on a purchase agreement with the founders and shareholders of CPM Partners regarding the acquisition of a majority stake in CPM Partners. The context CPM
Kellerhals Carrard advised Positrigo throughout its latest financing round. Raising an amount of CHF 7 million, the round in question was led by HealthCap, with participation from Navivo Capital as well as several family offices
Bär & Karrer has acted as Swiss legal and tax advisor to Holcim and its North American Amrize in planning the latter’s spin-off, corporate governance set-up, and public listing process. The Amrize shares
Kellerhals Carrard advised Swiss chocolate manufacturer Maestrani Schweizer Schokoladen on its acquisition of Delafaille, a family business specialising in the production of Belgian truffles and pralines. The acquisition also includes the selling part’s Czech
Vischer advised Easternmed Real Estate Capital in its acquisition of a new prime commercial property in Geneva. The building in question is home to a hotel residence. The company Headquartered in Nicosia and listed with
Welcome to “signed sealed weekend”, our inside track on what’s happening in the Swiss legal market. Without further ado, let’s go through our news highlights of the week. In January 2025, Laurent Killias (pictured
Homburger advised the Julius Baer Group on its issuance of EUR 500 m notes. The issuance The operation took place indirectly through the ELM issuance vehicle, a repackaging issuance entity incorporated in the Netherlands. The notes &
Homburger advised Raiffeisen Schweiz Genossenschaft in connection with its role as sole lead manager on EFG Bank’s issuance of CHF 125 m 0.9625% bonds, maturing in 2029. EFG Bank completed the issuance on June 18th. The Homburger
Kellerhals Carrard advised the Bern-based sports medicine start-up Pershing Medical in its acquisition of the Ligamys™ product line—a technology for the natural healing of the anterior cruciate ligament (ACL)—from the international medical technology
